Market Closed -
Other stock markets
|
After market 14:59:04 | |||
77.6 EUR | -2.76% |
|
77.58 | -0.03% |
06-24 | BioNTech, Duality Biologics Receive FDA Fast-Track Designation for Prostate Cancer Drug | MT |
06-24 | BioNTech Cancer Treatment Gets US FDA Fast Track Designation | DJ |
Sales 2024 * | 2.75B 2.93B 4.02B | Sales 2025 * | 2.74B 2.93B 4.01B | Capitalization | 19.02B 20.32B 27.84B |
---|---|---|---|---|---|
Net income 2024 * | -419M -447M -613M | Net income 2025 * | -548M -585M -802M | EV / Sales 2024 * | 2.31 x |
Net cash position 2024 * | 12.67B 13.53B 18.54B | Net cash position 2025 * | 12.02B 12.84B 17.59B | EV / Sales 2025 * | 2.56 x |
P/E ratio 2024 * |
-43.6
x | P/E ratio 2025 * |
-34.5
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | -2.79% | ||
1 week | -3.18% | ||
Current month | -15.88% | ||
1 month | -13.49% | ||
3 months | -9.05% | ||
6 months | -19.64% | ||
Current year | -18.33% |
![Extreme 77.6](/images/extremecours_fleche.png)
![Extreme 77.6](/images/extremecours_fleche.png)
![Extreme 77.6](/images/extremecours_fleche.png)
![Extreme 77.6](/images/extremecours_fleche.png)
![Extreme 77.6](/images/extremecours_fleche.png)
![Extreme 65.5](/images/extremecours_fleche.png)
![Extreme 65.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-26 | 77.6 | -2.76% | 31 658 |
24-06-25 | 79.8 | -1.36% | 19,760 |
24-06-24 | 80.9 | +2.34% | 71,845 |
24-06-21 | 79.05 | -1.74% | 46,520 |
24-06-20 | 80.45 | +0.37% | 41,471 |
Delayed Quote Xetra, June 26, 2024 at 11:42 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.50% | 122B | |
+21.43% | 116B | |
+22.18% | 27.03B | |
-16.89% | 16.43B | |
-18.28% | 15.91B | |
-44.74% | 15.6B | |
+61.96% | 14.94B | |
+3.33% | 13.59B | |
+122.52% | 11.24B |
- Stock Market
- Equities
- BNTX Stock
- 22UA Stock